FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic CancerThierry Conroy, Jean‐Baptiste Bachet, Pascal Artru et al.|New England Journal of Medicine|2018Cited by 2.8k
Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic CancerThierry Conroy, Jean François Seitz, Florence Castan et al.|JAMA Oncology|2022Cited by 322
Thymidylate Synthase Gene Polymorphism Predicts Toxicity in Colorectal Cancer Patients Receiving 5-Fluorouracil-based ChemotherapyThierry Lecomte, Pierre Laurent‐Puig, Jean‐Marc Ferraz et al.|Clinical Cancer Research|2004Cited by 241
Glutathione <i>S</i>-Transferase P1 Polymorphism (Ile105Val) Predicts Cumulative Neuropathy in Patients Receiving Oxaliplatin-Based ChemotherapyThierry Lecomte, Marie‐Anne Loriot, Bruno Landi et al.|Clinical Cancer Research|2006Cited by 210